Biomol Research Laboratoryt

Basic Information

5166 Campus Drive
Plymouth Meeting, PA, 19462

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Farnesyltransferase Inhibitors As Anticancer Agents

    Amount: $50,000.00

    The goal of the research is to develop a potent, pharmacologically useful inhibitor of farnesyltransferase for use as a new therapeutic agent for cancer. The Ras family of oncogenes and proto-oncogene ...

    SBIR Phase I 1993 Department of Health and Human Services
  2. Tyrosine Phosphatase Inhibitors As New Immunomodulators

    Amount: $49,834.00

    The goal of the research is to develop a potent pharmacologically useful inhibitor of the CD45 protein tyrosine phosphatase. CD45 is a transmembrane protein having a highly glycosylated extracellular ...

    SBIR Phase I 1993 Department of Health and Human Services
  3. NOVEL ANTICANCER DRUGS BASED ON GLYCOLIPID DEPLETION

    Amount: $50,000.00

    THE GOAL OF THE RESEARCH IS TO DEVELOP A POTENT PHARMACOLOGICALLY USEFUL INHIBITOR OF GLYCOSPHINGOLIPID (GSL) BIOSYNTHESIS. GSLS PLAY IMPORTANT ROLES IN (1) CANCER CELL METASTASIS, PROLIFERATION, AND ...

    SBIR Phase I 1992 Department of Health and Human Services
  4. NOVEL THERAPEUTIC AGENT FOR MYOCARDIAL INFARCTION

    Amount: $50,000.00

    THE GOAL OF THIS RESEARCH IS TO DEVELOP A POTENT AND SPECIFIC PHARMACOLOGICALLY USEFUL ANTAGONIST TO THE LEUKOTRIENE B4 (LTB4) RECEPTOR FOR USE AS A NEW THERAPEUTIC AGENT IN MYOCARDIAL INFARCTION. LTB ...

    SBIR Phase I 1990 Department of Health and Human Services
  5. RADIO IMMUNOASSAY KITS FOR PLATELET ACTIVATING FACTOR

    Amount: $50,000.00

    THE GOAL OF THE PROPOSED RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR PLATELET ACTIVATING FACTOR (PAF). PAF IS A LIPID MEDIATOR PRODUCED BY A VARIETY OF INFLAMMATORY CEL ...

    SBIR Phase I 1988 Department of Health and Human Services
  6. THE GOAL OF THIS RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR LEUKOTRIENE E4 AND LEUKOTRIENE E4-N-ACETATE, TWO IMPORTANT METABOLITES OF LEUKOTRIENE C4 AND D4.

    Amount: $50,000.00

    THE GOAL OF THIS RESEARCH IS TO DEVELOP A HIGHLY SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR LEUKOTRIENE E4 AND LEUKOTRIENE E4-N-ACETATE, TWO IMPORTANT METABOLITES OF LEUKOTRIENE C4 AND D4. THESE LEUK ...

    SBIR Phase I 1986 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government